Lucid Diagnostics Provides Business Update and Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
November 14, 2023 2:31 PM ESTCantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $3.80 (from $4.00) while maintaining a Overweight rating.
The analyst comments "
Investment Summary. We reiterate our Overweight rating while we moderate our 12-month price target to $3.80 from $4.00 on Lucid... More
